Amniocentesis: Procedure, Indications, Risks, and What to Expect

Amniocentesis is a prenatal diagnostic procedure performed typically between 15–20 weeks of gestation. Under ultrasound guidance, a thin needle is inserted through the abdominal wall into the amniotic sac to withdraw a small amount (15–20 mL) of amniotic fluid containing fetal cells.

Primary Indications

  • Advanced maternal age (≥ 35 years at delivery).
  • Positive screening test (e.g., NIPT, first-trimester combined screening).
  • Previous child with chromosomal abnormality or neural tube defect.
  • Parental chromosomal rearrangement (balanced translocation).
  • Fetal structural anomalies on ultrasound.
  • Assessment of fetal lung maturity (late pregnancy).
  • Diagnosis of fetal infection (e.g., CMV, toxoplasmosis).

What It Detects

  • Chromosomal abnormalities (Down syndrome, trisomy 18, trisomy 13, sex chromosome disorders).
  • Genetic disorders (cystic fibrosis, sickle cell disease, Tay-Sachs) via DNA analysis.
  • Neural tube defects (spina bifida, anencephaly) via alpha-fetoprotein (AFP) and acetylcholinesterase.
  • Fetal sex.

Risks & Limitations

  • Miscarriage risk: ~0.1–0.3% (1 in 300–1,000) with experienced operators.
  • Rh sensitization (Rh-negative mothers receive RhIg).
  • Transient amniotic fluid leakage, cramping, spotting.
  • Does not detect all birth defects (e.g., autism, cleft palate without genetic cause).
  • Results typically take 1–3 weeks (rapid FISH/karyotype available sooner).

Decision-Making

Discuss benefits, risks, and alternatives (NIPT, CVS) with a genetic counselor or maternal-fetal medicine specialist. The choice is personal and should align with your values and circumstances.

Infertility - Related Articles